Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 5 | 2500.00 | 1529.25 | 3792.00 | 3689.50 | 1.0278 | 1.0436 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 5 | 2500.00 | 1529.25 | 3792.00 | 3689.50 | 1.0278 | 1.0436 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 5 | 2500.00 | 1529.25 | 3656.00 | 3689.50 | 0.9909 | 0.9857 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 5 | 2500.00 | 1529.25 | 3937.00 | 3689.50 | 1.0671 | 1.1049 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 5 | 2500.00 | 1529.25 | 3622.00 | 3689.50 | 0.9817 | 0.9712 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 5 | 2500.00 | 1529.25 | 3878.00 | 3689.50 | 1.0511 | 1.0800 |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3928.00 | 3689.50 | 1.0646 | 1.1011 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 5 | 2500.00 | 1529.25 | 3788.00 | 3689.50 | 1.0267 | 1.0419 |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3795.00 | 3689.50 | 1.0286 | 1.0449 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 5 | 2500.00 | 1529.25 | 3980.00 | 3689.50 | 1.0787 | 1.1229 |
| SK-BR-3 | Etoposide | 0.01 | uM | 5 | 2500.00 | 1529.25 | 3795.00 | 3689.50 | 1.0286 | 1.0449 |
| SK-BR-3 | Etoposide | 1 | uM | 5 | 2500.00 | 1529.25 | 1980.00 | 3689.50 | 0.5367 | 0.2255 |
| SK-BR-3 | PLX-4720 | 10 | uM | 5 | 2500.00 | 1529.25 | 3443.00 | 3689.50 | 0.9332 | 0.8941 |
| SK-BR-3 | Etoposide | 10 | uM | 5 | 2500.00 | 1529.25 | 1839.00 | 3689.50 | 0.4984 | 0.1562 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 5 | 2500.00 | 1529.25 | 3824.00 | 3689.50 | 1.0365 | 1.0572 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 5 | 2500.00 | 1529.25 | 3416.00 | 3689.50 | 0.9259 | 0.8824 |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3501.00 | 3689.50 | 0.9489 | 0.9191 | |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3385.00 | 3689.50 | 0.9175 | 0.8689 | |
| SK-BR-3 | 0 | uM | 5 | 5000.00 | 1298.44 | 5742.00 | 5806.25 | 0.9889 | 0.9897 | |
| SK-BR-3 | 0 | uM | 5 | 5000.00 | 1298.44 | 5753.00 | 5806.25 | 0.9908 | 0.9915 | |
| SK-BR-3 | Etoposide | 19.9526 | uM | 5 | 5000.00 | 1298.44 | 2796.00 | 5806.25 | 0.4816 | 0.4261 |
| SK-BR-3 | 0 | uM | 5 | 5000.00 | 1298.44 | 5812.00 | 5806.25 | 1.0010 | 1.0009 | |
| SK-BR-3 | Nilotinib | 0.1 | uM | 5 | 5000.00 | 1298.44 | 5897.00 | 5806.25 | 1.0156 | 1.0144 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 5 | 5000.00 | 1298.44 | 5571.00 | 5806.25 | 0.9595 | 0.9621 |
| SK-BR-3 | Nilotinib | 10 | uM | 5 | 5000.00 | 1298.44 | 3019.00 | 5806.25 | 0.5200 | 0.4777 |